#mrna

3 briefings

Moderna and Merck's Personalized Cancer Vaccine Clears Its First Phase 3 Test

Aug 22, 2026, 9:05 PM

Spot Bio Debuts with $40M to Test mRNA Fix for Muscular Dystrophy

Jun 17, 2026, 5:33 PM

FDA Clears Path for Moderna's mRNA Flu Shot With No Major Red Flags

Jun 17, 2026, 12:55 AM